Sign in

CIK 0001479615

  • Non-accelerated filer
  • Smaller reporting company

Silence Therapeutics plc

Sign in to watch
Tickers
SLN SLNCF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 2034576900
Business address
12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP

Securities

  • SLN American Depository Share Nasdaq
  • SLNCF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-02 Lemus David Director Grant or award · Share Option (Right to Buy) +90,000 90,000
2025-01-02 Lemus David Director Grant or award · Share Option (Right to Buy) +48,000 48,000

Page 1 of 1 · 2 trades